Graphene-Based Biosensor Paves way for Diagnostics
A graphene-based biosensor with a molecular carbon intermediate layer has been developed to detect specific biomarkers.
Read MorePosted by Chris Wolski | Nov 29, 2024 | Immunoassay |
A graphene-based biosensor with a molecular carbon intermediate layer has been developed to detect specific biomarkers.
Read MorePosted by Andy Lundin | Nov 29, 2024 | Cancer, Miscellaneous, Point-of-Care |
The Center for Innovation and Translation of POC Technologies for Equitable Cancer Care showcased POC innovations for cancer detection.
Read MorePosted by Andy Lundin | Nov 27, 2024 | Company News, Sepsis |
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MorePosted by Andy Lundin | Nov 19, 2024 | Sexually Transmitted Diseases |
NOWDiagnostics has launched the First To Know Syphilis Test, an FDA-authorized over-the-counter syphilis test in the U.S.
Read MorePosted by Andy Lundin | Nov 19, 2024 | Point-of-Care, Sample Storage & Management |
Fluxergy is collaborating with NIAID to enhance molecular testing and sample preparation on its innovative platform.
Read More